Ion Beam Applications, SA

IBAB

BE0003766806

Advanced Medical Equipment & Technology

Market Closed - Euronext Bruxelles Other stock markets 10:25:00 16/01/2026 pm IST			5-day change	1st Jan Change
14.04 ^EUR	-1.40%		+0.57%	+8.67%

29/12	European stocks hit fresh record close as tech, staples drive post-holiday gains	RE
29/12	IBA Signs Contract For ProteusPlus In South Korea	RE

Ion Beam Applications Lands Order for Proton Therapy System in UAE

Published on 12/08/2025 at 12:22 pm IST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Ion Beam Applications, SA

29/12	European stocks hit fresh record close as tech, staples drive post-holiday gains	RE
29/12	IBA Signs Contract For ProteusPlus In South Korea	RE
26/12	Ion Beam Applications Bags Proton Therapy System Contract in South Korea	MT
26/12	Ion Beam Applications S.A. Signs Contract for a Three-Room Proteus®PLUS Solution to Be Installed at the Seoul St. Mary's Hospital	CI
19/12	Ion Beam Applications Buys Radiopharmaceutical Synthesizer Producer ORA	MT
19/12	IBA acquires radiochemistry company ORA in Belgium	RE
19/12	Ion Beam Applications SA acquired Optimized Radiochemical Applications Sprl for an estimated ?20 million.	CI
15/12	IBA says the Lancet recommends proton therapy as new standard of care for patients with oropharyngeal cancer	RE
11/12	IBA signed a contract with China Gold Irradiation (CGI)	RE
11/12	China Gold Irradiation Introduces Ion Beam Applications SA's Sustainable X-Ray Irradiation Technology to Expand Its Production Capacity	CI
08/12	Ion Beam Applications Lands Order for Proton Therapy System in UAE	MT
08/12	IBA to install Proteus One compact proton therapy solution in Dubai	RE
20/11	Ion Beam Applications SA, Q3 2025 Earnings Call, Nov 20, 2025
20/11	Ion Beam Applications SA Announces Official Opening of New Asia Headquarters in Beijing	CI
20/11	Ion Beam Applications FY2025 REBIT guidance confirmed at least EUR 25 mln	RE
03/11	Ion Beam Applications SA acquired Phantomx GmbH.	CI
03/11	Ion Beam Applications Buys PhantomX	MT
03/11	Ion Beam announces acquisition of Phantomx GmbH	RE
09/25/09	Universitätsklinikum Heidelberg completed the acquisition of State of Art Proteus ONE Proton Therapy Facility in Heidelberg, Germany of Ion Beam Applications SA.	CI
28/25/28	Ion Beam Applications SA, H1 2025 Earnings Call, Aug 28, 2025
28/25/28	Ion Beam Applications SA Reaffirms Earnings Guidance for the Year 2025	CI
28/25/28	IBA H1 rebit at 10.6 mln euros	RE
28/25/28	Tranche Update on Ion Beam Applications SA's Equity Buyback Plan announced on March 31, 2025.	CI
28/25/28	Ion Beam Applications SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
20/25/20	Ion Beam Applications S.A. Signs Contract to Install A Proteus One Compact Proton Therapy Solution to Be Located on the University Campus in Heidelberg, Germany	CI

Chart Ion Beam Applications, SA

Duration

Period

IBAB: Dynamic Chart

Ion Beam Applications, SA (IBA) specializes in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. Net sales break down by family of products as follows: - diagnosis and therapeutic treatment equipment and systems (86.9%): proton therapy equipment (55.5% of net sales; No. 1 worldwide), and particle accelerators (44.5%) used in the production of radioisotopes (cyclotrons) and in the development of sterilization and ionization solutions (Rhodotron® and Dynamitron®); - equipment and solutions of dosimetry (13.1%; No. 1 worldwide): measurement and analysis tools of the radiation doses in medical imaging and radiation therapy. Net sales are distributed geographically as follows: Belgium (1.1%), the United States (31.2%) and other (67.7%).

Employees

2,100

Sector

Advanced Medical Equipment & Technology

Calendar

19/03 - Q4 2025 Earnings Release (Projected)

More about the company